Phase 2 Asthma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who completed all required visits in the earlier ("parent") study, up to and including the final treatment visit.
- People who are willing and able to attend scheduled appointments, follow the treatment plan, complete lab tests, answer questionnaires, and keep an electronic diary throughout the study.
- People who agree to use contraception as required by the study and any local rules.
Who may not be able to join:
- People who had a significant change in their health during the parent study that, in the investigator's opinion, could affect their safety, the study results, or their ability to follow study procedures.
- People who experienced a side effect or health problem during the parent study that, in the opinion of the investigator or the study's medical monitor, could mean continuing treatment would carry unreasonable risk.
- People who were permanently taken off the study treatment for any reason during the parent study.
- People who are employees or immediate family members of the company running the trial, or of the research team at the trial site.
- People who, for any other reason, the investigator considers unsuitable to participate, including concerns that they may not be able to follow study procedures.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 857-285-5300
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of treatment-emergent adverse events (TEAEs); Incidence of treatment-emergent serious adverse events (SAEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.